1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	166_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	166_QUEST_clinical_caseMIR	SENT1	-	-
3	30	30		-	-	9-11	166_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	166_QUEST_clinical_caseMIR	SENT1	-	-
5	y	y	CC	C1706368	calificador	17-18	166_QUEST_clinical_caseMIR	SENT1	-	-
6	antecedentes	antecedente	NCMP000	-	-	19-31	166_QUEST_clinical_caseMIR	SENT1	-	-
7	patológicos	patológico	AQ0MP0	C1521733	calificador	32-43	166_QUEST_clinical_caseMIR	SENT1	-	-
8	de	de	SPS00	C0332285	atributo	44-46	166_QUEST_clinical_caseMIR	SENT1	-	-
9	esclerosis	esclerosis	NCFN000	C0026769_1	trastorno_1	47-57	166_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
10	múltiple	múltiple	NC00SC0	C0026769_2	trastorno_2	58-66	166_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
11	que	que	PR0CN000	-	-	67-70	166_QUEST_clinical_caseMIR	SENT1	-	-
12	acude	acudir	VMIP3S0	-	-	71-76	166_QUEST_clinical_caseMIR	SENT1	-	-
13	por	por	SPS00	C0678226	atributo	77-80	166_QUEST_clinical_caseMIR	SENT1	-	-
14	miodesopsias	miodesopsia	NCFP000	-	-	81-93	166_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	en	en	SPS00	C1720294#C0332285	calificador#atributo	94-96	166_QUEST_clinical_caseMIR	SENT1	-	-
16	ambos	ambos	PI0MP000	C1456809#C0229118_1	estructura_corporal_1	97-102	166_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
17	ojos	ojo	NCMP000	C1456809#C0229118_2	estructura_corporal_2	103-107	166_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
18	de	de	SPS00	C0332285	atributo	108-110	166_QUEST_clinical_caseMIR	SENT1	-	-
19	una	una		C0205447_1	calificador_1	111-114	166_QUEST_clinical_caseMIR	SENT1	-	-
20	semana	semana	NCFS000	C0439230	calificador	115-121	166_QUEST_clinical_caseMIR	SENT1	-	-
21	de	de	SPS00	C0332285	atributo	122-124	166_QUEST_clinical_caseMIR	SENT1	-	-
22	evolución	evolución	NCFS000	-	-	125-134	166_QUEST_clinical_caseMIR	SENT1	-	-
23	.	.	Fp	-	-	134-135	166_QUEST_clinical_caseMIR	SENT1	-	-

1	La	el	DA0FS0	-	-	136-138	166_QUEST_clinical_caseMIR	SENT2	-	-
2	exploración	exploración	NCFS000	C1280903	procedimiento	139-150	166_QUEST_clinical_caseMIR	SENT2	-	-
3	de	de	SPS00	C0332285	atributo	151-153	166_QUEST_clinical_caseMIR	SENT2	-	-
4	fondo	fondo	NCMS000	C0016823#C1284756#C0029090_1	estructura_corporal#procedimiento_1	154-159	166_QUEST_clinical_caseMIR	SENT2	-	-
5	de	de	SPS00	C0016823#C1284756#C0029090_2	estructura_corporal#procedimiento_2	160-162	166_QUEST_clinical_caseMIR	SENT2	-	-
6	ojo	ojo	NCMS000	C0016823#C1284756#C0029090_3	estructura_corporal#procedimiento_3	163-166	166_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
7	muestra	mostrar	VMIP3S0	-	-	167-174	166_QUEST_clinical_caseMIR	SENT2	-	-
8	vitritis	vitritis	NC00SC0	C0235812	trastorno	175-183	166_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
9	,	,	Fc	-	-	183-184	166_QUEST_clinical_caseMIR	SENT2	-	-
10	conglomerados	conglomerado	NCMP000	-	-	185-198	166_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
11	inflamatorios	inflamatorio	AQ0MP0	C0333348	calificador	199-212	166_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-
12	en	en	SPS00	C1720294#C0332285	calificador#atributo	213-215	166_QUEST_clinical_caseMIR	SENT2	-	-
13	forma	forma	NCFS000	C0348078	atributo	216-221	166_QUEST_clinical_caseMIR	SENT2	-	-
14	de	de	SPS00	C0332285	atributo	222-224	166_QUEST_clinical_caseMIR	SENT2	-	-
15	"	"	Fe	-	-	225-226	166_QUEST_clinical_caseMIR	SENT2	-	-
16	bolas	bola	NCFP000	-	-	226-231	166_QUEST_clinical_caseMIR	SENT2	-	-
17	de	de	SPS00	C0332285	atributo	232-234	166_QUEST_clinical_caseMIR	SENT2	-	-
18	nieve	nieve	NCFS000	C1611690	sustancia	235-240	166_QUEST_clinical_caseMIR	SENT2	-	-
19	"	"	Fe	-	-	240-241	166_QUEST_clinical_caseMIR	SENT2	-	-
20	en	en	SPS00	C1720294#C0332285	calificador#atributo	242-244	166_QUEST_clinical_caseMIR	SENT2	-	-
21	cavidad	cavidad	NCFS000	C1510420	anomalía_morfológica	245-252	166_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
22	vitrea	vitrea	AQ0FS00	-	-	253-259	166_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
23	inferior	inferior	AQ0CS0	C0542339#C0205104	calificador	260-268	166_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
24	y	y	CC	C1706368	calificador	269-270	166_QUEST_clinical_caseMIR	SENT2	-	-
25	periflebitis	periflebitis	NC00SC0	C0031129	trastorno	271-283	166_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
26	periférica	periférico	AQ0FS0	C0205100	calificador	284-294	166_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
27	en	en	SPS00	C1720294#C0332285	calificador#atributo	295-297	166_QUEST_clinical_caseMIR	SENT2	-	-
28	ambos	ambos	PI0MP000	C1456809#C0229118_1	estructura_corporal_1	298-303	166_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
29	ojos	ojo	NCMP000	C1456809#C0229118_2	estructura_corporal_2	304-308	166_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
30	.	.	Fp	-	-	308-309	166_QUEST_clinical_caseMIR	SENT2	-	-

